Why gene therapy for sickle cell is slow to catch on with patients
By Deena Beasley LOS ANGELES (Reuters) – Student Zoe Davis, 20, was just weeks into her junior year when she...
Read moreBy Deena Beasley LOS ANGELES (Reuters) – Student Zoe Davis, 20, was just weeks into her junior year when she...
Read moreFRANKFURT (Reuters) – Thyssenkrupp (ETR:TKAG)’s 27,000 steel workers must brace for deep cuts, the new head of the conglomerate’s steel...
Read moreInvesting.com — Shares of Ceres Power Holdings plc (LON:CWR) surged 20% on Friday following its first half results, which delivered...
Read moreInvesting.com — Deutsche Bank on Thursday resumed coverage of Dell Technologies (NYSE:DELL) with a Buy rating and a price target...
Read moreInvesting.com — Bumble Inc (NASDAQ:BMBL) shares dropped in premarket US trading on Friday after analysts at KeyBanc downgraded their rating...
Read moreInvesting.com — Bristol-Myers Squibb (NYSE:BMY) shares rallied 4.45% in premarket trading Friday following the announcement that the U.S. Food and...
Read more(Reuters) – Talks between the International Longshoremen’s Association (ILA), which represents 45,000 port workers, and the United States Maritime Alliance...
Read moreBy Johann M Cherian and Purvi Agarwal (Reuters) -U.S. stock index futures climbed on Thursday after Micron’s upbeat forecast revived...
Read moreSYDNEY (Reuters) – Australia’s two dominant grocery chains have declared interests in more than 150 unrealised development sites, the antitrust...
Read moreInvesting.com — HSBC analysts believe investors should look for opportunities among stocks with less demanding valuations as the S&P 500...
Read moreCopyright © 2025 Insightfulword.com. All Rights Reserved.